Previous 10 | Next 10 |
home / stock / medif / medif news
MediPharm Labs Corp. Announces Voting Results From Special Meeting of Shareholders Canada NewsWire BARRIE, ON , March 21, 2023 /CNW/ - MediPharm Labs Corp . (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm", or "MediPharm Labs") is pleased to announce that t...
MediPharm Labs Provides Update on Clinical Trial Progress Including FDA Approval of Partner Study Canada NewsWire MediPharm Labs shares progress on clinical trials, including the provision of clinical trial materials and research support to multiple partners. Research supp...
MediPharm Labs Corp. Announces Mailing and Filing of Joint Circular for Special Meeting of Shareholders to approve Arrangement with VIVO Cannabis Inc. Canada NewsWire BARRIE, ON , Feb. 21, 2023 /CNW/ - MediPharm Labs Corp . (TSX: LABS) (OTCQX: MEDIF) (FSE: ML...
MediPharm Labs Corp. to Acquire VIVO Cannabis Inc. Canada NewsWire Two global leaders in the medical wellness cannabis industry expected to combine complementary strengths of diversified revenue in multiple markets and channels to create a pro-forma Combined Company with over ...
MediPharm Labs Corp. (MEDIF) Q3 2022 Earnings Conference Call November 14, 2022, 08:30 AM ET Company Participants David Pidduck - CEO Keith Strachan - President Greg Hunter - CFO Conference Call Participants Remy Smith - Alliance Global Partners T...
MediPharm Labs Reports Third Quarter Results Canada NewsWire TORONTO , Nov. 14, 2022 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-base...
MediPharm Labs Sets Date to Report Third Quarter 2022 Financial Results PR Newswire BARRIE, ON , Nov. 9, 2022 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm" or the "Company") a...
MediPharm Labs Completes Sale of Australian Facility for Proceeds of $7,250,000 AUD Canada NewsWire BARRIE, ON , Oct. 7, 2022 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm Labs" or the "Company") a pharmaceutical compa...
MediPharm Labs Corp. (MEDIF) Q2 2022 Earnings Conference Call August 15, 2022 08:30 ET Company Participants David Pidduck - Chief Executive Officer Keith Strachan - President Greg Hunter - Chief Financial Officer Conference Call Participants Remy Smit...
MediPharm Labs Reports Second Quarter Results Canada NewsWire TORONTO , Aug. 15, 2022 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-bas...
News, Short Squeeze, Breakout and More Instantly...
MediPharm Labs Announces Voting Results From the 2024 Annual Meeting of Shareholders Canada NewsWire TORONTO , June 26, 2024 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical comp...
MediPharm Labs Acquires Advanced Medical Cannabis Delivery Method Technology from Remidose Aerosols Canada NewsWire MediPharm has licenced global manufacturing, distribution, and sales rights of the novel advanced medical cannabis technology from Remidose Aerosols. Product...